February over with no news. What's the nwbo excuse of the month for March, 2021? | NWBO Message Board Posts

Northwest Biotherapeutics Inc.

  NWBO website

NWBO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  14315 of 14407  at  3/2/2021 5:42:21 PM  by

Hodag


 In response to msg 14314 by  longfellow95
view thread

Re: February over with no news. What's the nwbo excuse of the month for March, 2021?

I think the key to getting favorable NICE pricing is the efficacy for the average patient.  If the data has a lot of outlier patients that live a very long time that is great for those patients, but not for the pricing.  If all the patients tend to live roughly the same amount of time after start of therapy, then NICE has a better idea of what price to accept.  Variance is not your friend.  Which is another reason why diagnostic markers, like meth and non-meth, are important; it lets the NICE price the therapy differentially to allow the patients most likely to benefit to obtain the drug.  Nobody likes to think about patients not getting access for economic reasons, but that will increasingly be the reality going forward.  Those are not easy decisions to make. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
14316 Re: February over with no news. What's the nwbo excuse of the month for March, 2021? iclight 0 3/3/2021 12:34:42 PM
14317 Re: February over with no news. What's the nwbo excuse of the month for March, 2021? longfellow95 0 3/3/2021 6:29:45 PM








Financial Market Data provided by
.
Loading...